Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
The New Era of RAS Targeting: Mechanisms, Evidence, and Clinical Integration of ON-State Inhibitors
Kathryn Arbour
Eileen M. O'Reilly, MD
Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations
Case Review: Can You Crack This IBD Case?
David Rubin, MD
Kimberly D. Orleck, PA-C
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?
Jennifer Geremia, PA-C
Tailoring Treatment: Can You Select the Best Therapy?
Brooke Hodnick, PA-C, MPAS
Severity Assessment: Can You Pin the Stage on the Patient?
Remission: Can You Prove It?
Treat-to-Target: Are We There Yet?
Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
Case Review: Targets Are Met—Can You Stick the Landing?
IBD Immunopathogenesis: Do You Know What You're Blocking?
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
Pushpa Narayanaswami, MD, FAAN
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
A.J. Gelderblom, MD, PhD
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
María-Victoria Mateos, MD, PhD
Luciano Costa, M.D., Ph.D.
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Cristina Rodriguez, MD
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
All Sides of the Joint: Integrated TGCT Care Across Specialties
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
Switching Strategies: Switch or Stay—What’s Your Call?
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Linda Stein Gold, MD
Bruce Strober, MD, PhD
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Taking Action Against RSV: No Child Unprotected
Tina Q. Tan, MD
Yvonne Maldonado, MD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.